Evidence map›Paper›PMID 25798242›Full record

ArticleBiomedical reports2015

Analysis of gene expression profiles as a tool to uncover tumor markers of liver cancer progression in a rat model.

Verónica R Vásquez-Garzón, Olga Beltrán-Ramírez, Martha E Salcido-Neyoy, Nancy Cervante-Anaya, Saúl Villa-Treviño

Open access · hybridAbstract read
In one paragraph

Article in Biomedical reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Liver Cancer: Therapeutic Challenges and the Importance of Experimental Models.Canadian journal of gastroenterology & hepatology · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Verónica R Vásquez-GarzónDepartment of Cell Biology, Center for Research and Advanced Studies (CINVESTAV-IPN), México, DF 07360, México.
Olga Beltrán-RamírezDepartment Research, Hospital Juárez of México, México, DF 07760, México.
Martha E Salcido-NeyoyNational Cancer Institute, Colonia Sección XVI Delegación Tlalpan, México, DF 14080, México.
Nancy Cervante-AnayaDepartment of Cell Biology, Center for Research and Advanced Studies (CINVESTAV-IPN), México, DF 07360, México.
Saúl Villa-TreviñoDepartment of Cell Biology, Center for Research and Advanced Studies (CINVESTAV-IPN), México, DF 07360, México.
Cancer Institute (WIA) · INHospital Juárez de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Establishing a transcriptomic profile of human hepatocellular liver cancer (HCC) progression is a complex undertaking. A rat model of HCC was employed to develop a transcriptomic profile. Using three interventions, preneoplastic lesions appeared after 30 days and they progressed to HCC by 9 months. Preneoplastic and cancer lesions were characterized for transcriptomic analysis, and RNA from total liver homogenates was obtained at 1, 7, 11 and 16 days after the initiation treatment. RNA from dissected persistent preneoplastic lesions, adjacent tissue or cancer tissue was used for 30 days, and 5, 9, 12 and 18 months. The GeneChip

Indexed as

animal modelcancer markersgene expression profileliver cancertherapeutic targets

Identifiers

PMID25798242
PMCPMC4360884
OpenAlexW2088985323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.